Acclaimed Cardiology
Acclaimed Cardiology Expert Dr. Peter Libby To Keynote 19th Annual CMHC, Revolutionize Atherosclerosis Care
May 22, 2024 11:00 ET | Cardiometabolic Health Congress
Boca Raton, FL, May 22, 2024 (GLOBE NEWSWIRE) -- The Cardiometabolic Health Congress (CMHC) is proud to announce that one of the foremost authorities in atherosclerosis, Peter Libby, MD, will...
ZyversaREV_cmyk.jpg
ZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate in the 2024 BIO International Convention
May 14, 2024 07:57 ET | ZyVersa Therapeutics
To learn more about ZyVersa's Inflammasome ASC Inhibitor and Renal Pipelines, schedule a one-on-one meeting on 2024 BIO International Conference's Portal.
ZyversaREV_cmyk.jpg
ZyVersa Therapeutics Highlights Published Data Demonstrating NLRP3 Inflammasome Inhibition Has Potential to Decrease Atherosclerotic Lesions in Patients with Diabetes
April 04, 2024 07:57 ET | ZyVersa Therapeutics
Inhibiting inflammasome pathways has potential to attenuate atherosclerosis in patients with diabetes, a leading cause of morbidity & mortality.
ZyversaREV_cmyk.jpg
ZyVersa Therapeutics' CEO, Stephen C. Glover to Participate in a Panel Discussion Titled “Inflammation Illuminated,”at Benzinga’s Virtual Healthcare Summit 2024 on March 20, 2024
March 14, 2024 07:57 ET | ZyVersa Therapeutics
Mr. Glover will talk about inflammasomes, and how they trigger development and spread of damaging inflammation, the culprit behind many deadly diseases.
TIP_link_300x300.jpg
Endothelial Dysfunction Market to Reach $2.58Bn, Globally, by 2028 at 4.4% CAGR with Hypertension Segment Driving Growth During 2022-2028 | Report by The Insight Partners
August 11, 2023 06:41 ET | The Insight Partners
Pune, India, Aug. 11, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners latest study on “Endothelial Dysfunction Market Size Report & Share, Forecast to 2028 – COVID-19 Impact and...
TIP_link_300x300.jpg
Curcumin Market Growth Analysis Report - $135.5 Million, Globally, by 2028 at 9.1% CAGR – Comprehensive Study by The Insight Partners
March 20, 2023 10:54 ET | The Insight Partners
New York, March 20, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Curcumin Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global Analysis by...
Kizoo_Logo for GNW.jpg
Kizoo Portfolio Company Underdog Closes $10M Financing Round
September 23, 2021 07:00 ET | KIZOO Technology Capital GmbH
MOUNTAIN VIEW, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Underdog Pharmaceuticals, a key investment of Michael Greve's rejuvenation biotech VC Kizoo, has closed a $10 million round of capital....
Underdog_logo.png
Underdog Pharmaceuticals Awarded ‘Innovation Passport’ by UK Regulators
September 08, 2021 11:00 ET | Underdog Pharmaceuticals Inc.
MOUNTAIN VIEW, Calif., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Underdog Pharmaceuticals, Inc. (Underdog), a pre-clinical stage pharmaceutical company focusing on the treatment and reversal of age-related...
AMR Logo.png
Inflation Devices Market Size to Reach Valuation of $770 million by 2026 | AMR
February 15, 2021 10:00 ET | Allied Market Research
Portland, OR, Feb. 15, 2021 (GLOBE NEWSWIRE) -- According to the report, the global inflation devices market was valued at $517 million in 2018, and is expected to reach $770 million by 2026,...